Herbst, R.S., Prager, D., Hermann, R., et al. (2005) TRIBUTE: A Phase Ⅲ Trial of Erlotinib Hydrochloride (OSI2774) Combined with Carbop Latin and Paclitaxel Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 23, 5892-5899.